Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
12.27
-0.52 (-4.07%)
At close: Sep 12, 2025, 4:00 PM EDT
12.49
+0.22 (1.79%)
After-hours: Sep 12, 2025, 7:10 PM EDT
Tandem Diabetes Care Revenue
Tandem Diabetes Care had revenue of $240.68M in the quarter ending June 30, 2025, with 8.46% growth. This brings the company's revenue in the last twelve months to $1.00B, up 25.84% year-over-year. In the year 2024, Tandem Diabetes Care had annual revenue of $940.20M with 25.74% growth.
Revenue (ttm)
$1.00B
Revenue Growth
+25.84%
P/S Ratio
0.81
Revenue / Employee
$378,007
Employees
2,650
Market Cap
829.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 940.20M | 192.49M | 25.74% |
| Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
| Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
| Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
| Dec 31, 2020 | 498.83M | 136.53M | 37.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TNDM News
- 3 days ago - Tandem Diabetes Care, Inc. (TNDM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones - Business Wire
- 4 weeks ago - Top 3 Health Care Stocks That Are Preparing To Pump This Month - Benzinga
- 4 weeks ago - Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell - Seeking Alpha
- 5 weeks ago - Tandem Diabetes Care issues voluntary device correction for certain insulin pumps - Reuters
- 5 weeks ago - Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps - Business Wire
- 5 weeks ago - Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
- 5 weeks ago - Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Earnings Call Transcript - Seeking Alpha